
Capital advanced in exchange for a share of future revenue from a specific product or asset.
Royalty financing provides capital in exchange for a percentage of future revenue from a defined product, patent, or asset. Unlike revenue-based financing, which is usually tied to whole-company revenue and capped by a multiple, a royalty can be tied to a single asset and may run for a defined term or in perpetuity.
It is most established in pharmaceuticals, natural resources, music catalogues, and licensed technology — sectors where a specific asset produces identifiable, traceable income.
Used where a company owns a revenue-producing asset but needs capital without selling equity or taking on conventional debt. The investor is effectively buying a share of that asset's income stream, leaving ownership and control untouched.
Capital without dilution, board seats, or control transfer, and payments scale with the asset's actual performance. The obligation can outlast its usefulness — a perpetual royalty on a product that becomes the core business is very expensive in hindsight, which is why buyback rights matter.
Exposure to a specific asset's performance without operating responsibility, with returns typically arriving sooner than equity. Everything depends on the durability of the underlying asset and the precision of the revenue definition — ambiguity there is where disputes originate.
Global Capital Network connects founders and investors across every instrument on this list.
Explore OpportunitiesAll Instruments.png)




